Judge Upholds Zyprexa Patent

Law360 (April 15, 2005, 12:00 AM EDT) -- In a major victory for Eli Lilly & Co., an Indiana federal judge has upheld the patent on the key ingredient on its $4.4 billion-a-year Zyprexa schizophrenia drug.

U.S. District Court Judge Richard Young's decision came down in Lilly's favor on all accounts, leaving in effect a patent on the schizophrenia drug Zyprexa that runs through April of 2011.

The decision to uphold the patent on the key ingredient in Zyprexa is a defeat for Ivax Corp., Dr. Reddy's Laboratories Ltd. and Teva Pharmaceutical Industries Ltd.,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.